44
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Stilbenes at Low Micromolar Concentrations Mitigate the NO, TNF-α, IL-1β and ROS Production in LPS-Stimulated Murine Macrophages

, , , , , & show all
Pages 212-222 | Received 28 Dec 2020, Accepted 23 Apr 2021, Published online: 02 Jun 2021
 

Abstract

Stilbenes, of which resveratrol is the most studied, were described as antioxidant and anti-inflammatory molecules. Presumably, other stilbenes have similar biological properties, but the evidence is poorly documented. Therefore, 20 stilbenes from resveratrol monomers to tetramers were screened as anti-inflammatory and antioxidant agents in a cellular model of LPS-stimulated murine macrophages. Piceatannol (monomer), ϵ-viniferin and δ-viniferin (dimers), hopeaphenol and isohopeaphenol (tetramers) were the most powerful compounds that inhibited NO and ROS generation upon LPS exposure. Among these compounds, hopeaphenol (5-10 µM) showed the highest efficiency. Nevertheless, ϵ-viniferin was the most powerful to inhibit TNF-α release whereas isohopeaphenol was the greatest to reduce IL-1β upon LPS stimulation. Thus, this work provided evidence that the chemical structure of stilbenes is highly relevant to the behavior of their activities. These results will allow the selection of potential bioactive stilbenes to develop further studies to elucidate their molecular mechanism of action.

Graphical abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.